A carregar...

New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription

Conventional chemotherapy remains the primary treatment option for triple-negative breast cancer (TNBC). However, the current chemotherapeutic drugs have limited effects on TNBC, and often lead to serious side effects as well as drug resistance. Thus, more effective therapeutic options are sorely ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nucleic Acids Res
Main Authors: Hu, Ming-Hao, Wu, Tian-Ying, Huang, Qiong, Jin, Guangyi
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846596/
https://ncbi.nlm.nih.gov/pubmed/31584090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkz835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!